Correlation Between Symbotic and Nouveau Life

Can any of the company-specific risk be diversified away by investing in both Symbotic and Nouveau Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Symbotic and Nouveau Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Symbotic and Nouveau Life Pharmaceuticals, you can compare the effects of market volatilities on Symbotic and Nouveau Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Symbotic with a short position of Nouveau Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Symbotic and Nouveau Life.

Diversification Opportunities for Symbotic and Nouveau Life

-0.12

Correlation Coefficient

Symbotic  Nouveau Life

Good diversification

The 3 months correlation between Symbotic and Nouveau is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Symbotic and Nouveau Life Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nouveau Life Pharmac and Symbotic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Symbotic are associated (or correlated) with Nouveau Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nouveau Life Pharmac has no effect on the direction of Symbotic i.e., Symbotic and Nouveau Life go up and down completely randomly.

Pair Corralation between Symbotic and Nouveau Life

Considering the 90-day investment horizon Symbotic is expected to under-perform the Nouveau Life. But the stock apears to be less risky and, when comparing its historical volatility, Symbotic is 25.08 times less risky than Nouveau Life. The stock trades about -0.01 of its potential returns per unit of risk. The Nouveau Life Pharmaceuticals is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Nouveau Life Pharmaceuticals on December 2, 2024 and sell it today you would earn a total of  0.00  from holding Nouveau Life Pharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Symbotic  vs.  Nouveau Life Pharmaceuticals

Symbotic

Risk-Adjusted Performance

Very Weak

Over the last 90 days Symbotic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Symbotic is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Nouveau Life Pharmac

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Nouveau Life Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Nouveau Life showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Symbotic and Nouveau Life

The main advantage of trading using opposite Symbotic and Nouveau Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Symbotic position performs unexpectedly, Nouveau Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nouveau Life will offset losses from the drop in Nouveau Life's long position.

The idea behind Symbotic and Nouveau Life Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.